0

Motion Sickness Drugs Market by Product and Geography - Forecast and Geography 2022-2026

  • Published: Sep 2022
  • Pages: 132
  • SKU: IRTNTR74414
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The motion sickness drugs market is projected to grow by USD 119.64 million with a CAGR of 4.15% during the forecast period 2021 to 2026.

This motion sickness drugs market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers motion sickness drugs market segmentation by product (anticholinergics and antihistamines) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The motion sickness drugs market report also offers information on several market vendors, including Aurobindo Pharma Ltd, Baxter International Inc., Caleb Pharmaceuticals Inc, Cipla Ltd., CVS Health Corp., DM Pharma, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline Plc, Hylands, Johnson & Johnson, Lupin Ltd, Merck KGaA, Myungmoon Pharm Co. Ltd., Perrigo Co. Plc, Pfizer Inc., Prestige Consumer Healthcare Inc., Reliefband Technologies LLC, Viatris Inc., WellSpring Pharmaceutical Corp., and Zenomed Healthcare Pvt. Ltd, among others.

What will the Motion Sickness Drugs Market Size be During the Forecast Period?

Motion Sickness Drugs Market Size

Download Report Sample to Unlock the Motion Sickness Drugs Market Size for the Forecast Period and Other Important Statistics

 

Motion Sickness Drugs Market: Key Drivers, Trends, and Challenges

The availability of over-the-counter (OTC) drugs is notably driving the motion sickness drugs market growth, although factors such as non-pharmacological countermeasures to treat motion sickness may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the motion sickness drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Motion Sickness Drugs Market Driver

The availability of over-the-counter (OTC) drugs is one of the factors driving the motion sickness drugs market growth. Anticholinergics and antihistamines have been regarded as first-line therapy for suppressing and preventing the symptoms associated with motion sickness. Several antihistamines are available as OTC drugs and can be used by pediatric patients. Moreover, these drugs are largely being used to prevent the symptoms of motion sickness rather than treat it. OTC drugs are defined as medicines that are sold directly to patients or consumers without the need for a prescription from a healthcare professional. The availability of these medicines OTC increases their accessibility and affordability and provides patients with the freedom of self-medication for the treatment of symptoms associated with minor illnesses. Thus, the availability of OTC antihistamines increases their adoption among patients experiencing motion sickness, thereby fueling the market growth.

Key Motion Sickness Drugs Market Trend

The advent of nauseogenic information technology is one of the key motion sickness drugs market trends fueling the market growth. The nauseogenic information technology involves the use of nauseogenic vehicles that help in analyzing an individual's postural stability and can reveal the underlying neural or sensory-motor processes that help in achieving successful body stability. This technology has revealed that motion sickness often occurs within a narrow band of frequencies of the imposed oscillation. The frequency band obtained in patients with motion sickness is like that produced by postural sway during a natural stance. Research in this area is currently in its early stages, and further advances in nauseogenic information technology are anticipated to have a positive impact on market growth.

Key Motion Sickness Drugs Market Challenge

Non-pharmacological countermeasures to treat motion sickness are one of the factors limiting the motion sickness drugs market growth. Short-duration habituation training can be used to induce motion sickness habituation in both animals and humans. The training involves exposing the subject to prolonged periods of motion stimulation, and the training may last for up to several weeks. Repeated exposure to motion stimulation is beneficial in achieving the linear acceleration of acquiring motion sickness habituation. However, one single prolonged motion stimulus does not produce enough habituation. Therefore, the goal of motion sickness habituation training is to stimulate sensory conflict in the brain that resembles a provocative environment. These factors will limit the market growth in the forecast period.

This motion sickness drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global motion sickness drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the motion sickness drugs market during the forecast period.

Who are the Major Motion Sickness Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Aurobindo Pharma Ltd
  • Baxter International Inc.
  • Caleb Pharmaceuticals Inc
  • Cipla Ltd.
  • CVS Health Corp.
  • DM Pharma
  • Dr. Reddy's Laboratories Ltd
  • GlaxoSmithKline Plc
  • Hylands
  • Johnson & Johnson
  • Lupin Ltd
  • Merck KGaA
  • Myungmoon Pharm Co. Ltd.
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reliefband Technologies LLC
  • Viatris Inc.
  • WellSpring Pharmaceutical Corp.
  • Zenomed Healthcare Pvt. Ltd

 

This statistical study of the motion sickness drugs market encompasses successful business strategies deployed by the key vendors. The motion sickness drugs market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Baxter International Inc. - The company offers motion sickness drugs such as Dimenhydrinate. 

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

The motion sickness drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Motion Sickness Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the motion sickness drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for the Motion Sickness Drugs Market?

Motion Sickness Drugs Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

41% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the motion sickness drugs market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The increase in disposable income of people will facilitate the motion sickness drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID-19 Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 had a significant impact on the growth of the regional market. However, in 2021, the initiation of vaccination drives resulted in the lifting of lockdowns and the resumption of business operations. Such factors resulted in the moderate growth of the regional market and are expected to achieve the same pace of growth during the forecast period.

What are the Revenue-generating Product Segments in the Motion Sickness Drugs Market?

Motion Sickness Drugs Market Share

To gain further insights on the market contribution of various segments Request a PDF Sample

The motion sickness drugs market share growth in the anticholinergics segment will be significant during the forecast period. Hyoscine hydrobromide or scopolamine is an anticholinergic drug used for the prevention of motion sickness. Hyoscine is a naturally occurring alkaloid that competitively binds to muscarinic receptors, thus inhibiting the release of acetylcholine. It can penetrate the blood-brain barrier (BBB) owing to the lipophilic nature of hyoscine, thus exhibiting both central as well as parasympathetic effects. These factors will boost segment growth in the near future.

This report provides an accurate prediction of the contribution of all the segments to the growth of the motion sickness drugs market size and actionable market insights on the post-COVID-19 impact on each segment.

 

Motion Sickness Drugs Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 4.15%

Market growth 2022-2026

$119.64 million

Market structure

Fragmented

YoY growth (%)

3.67

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key consumer countries

US, Canada, UK, Germany, and China

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Aurobindo Pharma Ltd, Baxter International Inc., Caleb Pharmaceuticals Inc, Cipla Ltd., CVS Health Corp., DM Pharma, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline Plc, Hylands, Johnson and Johnson, Lupin Ltd, Merck KGaA, Myungmoon Pharm Co. Ltd., Perrigo Co. Plc, Pfizer Inc., Prestige Consumer Healthcare Inc., Reliefband Technologies LLC, Viatris Inc., WellSpring Pharmaceutical Corp., and Zenomed Healthcare Pvt. Ltd

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Motion Sickness Drugs Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive motion sickness drugs market growth during the next five years
  • Precise estimation of the motion sickness drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the motion sickness drugs industry across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of motion sickness drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Anticholinergics - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Anticholinergics - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Anticholinergics - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Anticholinergics - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Anticholinergics - Year-over-year growth 2021-2026 (%)
    • 5.4 Antihistamines - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Antihistamines - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Antihistamines - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Antihistamines - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Antihistamines - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Product
      • Exhibit 36: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Canada - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Germany - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Baxter International Inc.
              • Exhibit 85: Baxter International Inc. - Overview
              • Exhibit 86: Baxter International Inc. - Business segments
              • Exhibit 87: Baxter International Inc. - Key news
              • Exhibit 88: Baxter International Inc. - Key offerings
              • Exhibit 89: Baxter International Inc. - Segment focus
            • 10.4 Caleb Pharmaceuticals Inc
              • Exhibit 90: Caleb Pharmaceuticals Inc - Overview
              • Exhibit 91: Caleb Pharmaceuticals Inc - Product / Service
              • Exhibit 92: Caleb Pharmaceuticals Inc - Key offerings
            • 10.5 GlaxoSmithKline Plc
              • Exhibit 93: GlaxoSmithKline Plc - Overview
              • Exhibit 94: GlaxoSmithKline Plc - Business segments
              • Exhibit 95: GlaxoSmithKline Plc - Key offerings
              • Exhibit 96: GlaxoSmithKline Plc - Segment focus
            • 10.6 Johnson and Johnson
              • Exhibit 97: Johnson and Johnson - Overview
              • Exhibit 98: Johnson and Johnson - Business segments
              • Exhibit 99: Johnson and Johnson - Key news
              • Exhibit 100: Johnson and Johnson - Key offerings
              • Exhibit 101: Johnson and Johnson - Segment focus
            • 10.7 Myungmoon Pharm Co. Ltd.
              • Exhibit 102: Myungmoon Pharm Co. Ltd. - Overview
              • Exhibit 103: Myungmoon Pharm Co. Ltd. - Product / Service
              • Exhibit 104: Myungmoon Pharm Co. Ltd. - Key offerings
            • 10.8 Perrigo Co. Plc
              • Exhibit 105: Perrigo Co. Plc - Overview
              • Exhibit 106: Perrigo Co. Plc - Business segments
              • Exhibit 107: Perrigo Co. Plc - Key offerings
              • Exhibit 108: Perrigo Co. Plc - Segment focus
            • 10.9 Pfizer Inc.
              • Exhibit 109: Pfizer Inc. - Overview
              • Exhibit 110: Pfizer Inc. - Product / Service
              • Exhibit 111: Pfizer Inc. - Key news
              • Exhibit 112: Pfizer Inc. - Key offerings
            • 10.10 Prestige Consumer Healthcare Inc.
              • Exhibit 113: Prestige Consumer Healthcare Inc. - Overview
              • Exhibit 114: Prestige Consumer Healthcare Inc. - Business segments
              • Exhibit 115: Prestige Consumer Healthcare Inc. - Key offerings
              • Exhibit 116: Prestige Consumer Healthcare Inc. - Segment focus
            • 10.11 Reliefband Technologies LLC
              • Exhibit 117: Reliefband Technologies LLC - Overview
              • Exhibit 118: Reliefband Technologies LLC - Product / Service
              • Exhibit 119: Reliefband Technologies LLC - Key offerings
            • 10.12 WellSpring Pharmaceutical Corp.
              • Exhibit 120: WellSpring Pharmaceutical Corp. - Overview
              • Exhibit 121: WellSpring Pharmaceutical Corp. - Product / Service
              • Exhibit 122: WellSpring Pharmaceutical Corp. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 123: Inclusions checklist
                • Exhibit 124: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 125: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 126: Research methodology
                • Exhibit 127: Validation techniques employed for market sizing
                • Exhibit 128: Information sources
              • 11.5 List of abbreviations
                • Exhibit 129: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Motion Sickness Drugs market growth will increase by $119.64 million during 2022-2026.
              The motion sickness drugs market is expected to grow at a CAGR of 4.15% during 2022-2026.
              Technavio has segmented the motion sickness drugs market by geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Aurobindo Pharma Ltd, Baxter International Inc., Caleb Pharmaceuticals Inc, Cipla Ltd., CVS Health Corp., DM Pharma, Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hylands, Johnson and Johnson, Lupin Ltd, Merck KGaA, Myungmoon Pharm Co. Ltd., Perrigo Co. Plc, Pfizer Inc., Prestige Consumer Healthcare Inc., Reliefband Technologies LLC, Viatris Inc., WellSpring Pharmaceutical Corp., Zenomed Healthcare Pvt. Ltd are a few of the key vendors in the motion sickness drugs market.
              North America will register the highest growth rate of 40.91% among the other regions. Therefore, the motion sickness drugs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the motion sickness drugs market growth are:
              • Availability of over-the-counter (OTC) drugs
              • Advent of nauseogenic information technology
              The motion sickness drugs market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>